Ignite Creation Date:
2024-05-06 @ 3:19 AM
Last Modification Date:
2024-10-26 @ 11:32 AM
Study NCT ID:
NCT02268045
Status:
COMPLETED
Last Update Posted:
2019-09-26
First Post:
2014-09-19
Brief Title:
Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkins Lymphoma
Sponsor:
mAbxience Research SL
Organization:
mAbxience Research SL
Organization Data
Organization:
mAbxience Research SL
Class:
INDUSTRY
Study ID:
RTXM83-AC-01-11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
mAbxience Research SL
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pisa Farmacéutica | UNKNOWN |
| Laboratorios de Productos Éticos CEISA | UNKNOWN |
| Laboratorio Elea Phoenix SA | INDUSTRY |
| Tecnoquimicas SA | UNKNOWN |
| Innogene Kalbiotech Pte Ltd | INDUSTRY |
| Libbs Farmacêutica LTDA | INDUSTRY |
| Key Oncologics Pty Ltd | UNKNOWN |
| Nanolek LLC | OTHER |
| Actoverco | OTHER |